本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 成都思科瑞微电子股份有限公司（以下简称"公司"） 拟于 2025 年 5 月 16 日 14 点 00 分召开 2024 年年度股东大会，本次会议采用现场投票和网络投票相 结合的表决方式，详见公司于 2025 年 4 月 26 日在上海证券交易所网站 （www.sse.com.cn）披露的《成都思科瑞微电子股份有限公司关于召开 2024 年 年度股东大会的通知》（公告编号：2025-021）。为更好地服务广大中小投资者， 确保有投票意愿的中小投资者能够及时参会、及时投票，公司拟使用上证所信息 网络有限公司（以下简称"上证信息"）提供的股东会提醒服务，委托上证信息通 过智能短信等形式，根据股权登记日的股东名册主动提醒股东参会投票。投资者 在 收 到 智 能 短 信 后 ， 可 根 据 使 用 手 册 （ 下 载 链 接 ： https://vote.sseinfo.com/i/yjt_help.pdf）的提示步骤直接投票，如遇拥堵等情况， 仍可通过原有的交易系统投票平台和互联网 ...

成都思科瑞微电子股份有限公司 2024 年年度股东大会会议资料 证券代码：688053 证券简称：思科瑞 成都思科瑞微电子股份有限公司 会议资料 成都思科瑞微电子股份有限公 大会会议资料 司 2024 年年度股东 目 录 成都思科瑞微电子股份有限公司 2024 年年度股东大会会议资料 成都思科瑞微电子股份有限公司 为保障成都思科瑞微电子股份有限公司（以下简称"公司"）全体股东的合 法权益，维护股东大会的正常秩序，保证股东大会的议事效率，确保本次股东大 会如期、顺利召开，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《成都思科瑞微电子股份有限公司章程》 （以下简称"《公司章程》"）、 《成都思科 瑞微电子股份有限公司股东大会议事规则》及中国证券监督管理委员会、上海证 券交易所的有关规定，特制定本会议须知： 一、为确认出席大会的股东（或股东代表）或其他出席者的出席资格，会议 工作人员将对出席会议者的身份进行必要的核对工作，请被核对者给予配合。 二、为保证本次股东大会的严肃性和正常秩序，切实维护与会股东（或股东 代表）的合法权益，除出席会议的股东（或股东代表）、公司董事、监事、高级 管理人员、见证律师及 ...

成都思科瑞微电子股份有限公司 2024 年年度股东大会会议资料 证券代码：688053 证券简称：思科瑞 成都思科瑞微电子股份有限公司 2024 年年度股东大会 会议资料 2025 年 5 月 | 4 | | | | --- | --- | --- | | | . N | 1 | | 年年度股东大会会议须知 | 1 | 2024 | 年年度股东大会会议议程 | 4 | 2024 | | --- | --- | --- | --- | --- | --- | | 年年度股东大会会议议案 | 6 | 2024 | | | | | 《成都思科瑞微电子股份有限公司 | 年度财务决算报告》 27 | 2024 | | | | 成都思科瑞微电子股份有限公司 2024 年年度股东大会会议资料 成都思科瑞微电子股份有限公司 2024 年年度股东大会会议须知 为保障成都思科瑞微电子股份有限公司（以下简称"公司"）全体股东的合 法权益，维护股东大会的正常秩序，保证股东大会的议事效率，确保本次股东大 会如期、顺利召开，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《成都思科瑞微电子股份有限公司章程》（以下简称"《公司章 ...

对于亏损，思科瑞解释称，主要客户为各大军工集团下属单位及相关电子厂商，受军工行业人事调整、武器装备参数及型号调整等因素影响，军工行业处于 阶段性调整，订货需求量减少，检测订单量下滑。同时，市场竞争加剧导致部分检测业务价格下降，共同致使营业收入降低。 单季度看，2024年第四季度思科瑞实现营业收入4455.58万元，同比增长2.23%，环比增长2.05%；归母净亏损为2271.83万元，同比下降742.17%，环比下降 643.00%；扣非归母净亏损为2483.47万元，同比下降452.00%，环比下降735.83%。 4月26日，成都思科瑞微电子股份有限公司（以下简称"思科瑞"）发布2024年报。数据显示，2024年思科瑞营业收入为1.44亿元，同比下降28.40%；归母净 亏损为2100.32万元，同比下降143.90%；扣非归母净亏损为2602.10万元，同比下降161.25%；基本每股收益为-0.21元/股。 财务指标方面，2024年思科瑞毛利率为36.30%，同比下降17.67个百分点；净利率为-17.25%，同比下降40.45个百分点。 公开信息显示，思科瑞成立于2014年12月19日，上市日期为2 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688053 证券简称：思科瑞 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假 记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息的真 实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一) 主要会计数据和财务指标 单位：元 币种：人民币 (二) 非经常性损益项目和金额 √适用 □不适用 单位:元 币种:人民币 对公司将《公开发行证券的公司信息披露解释性公告第1号——非经常性损益》未列举的项目认定为非 经常性损益项目且金额重大的，以及将《公开发行证券的公司信息披露解释性公告第1号——非经常性 损益》中列举的非经常性损益项目界定为经常性损益的项目，应说明原因。 □适用 √不适用 (三) 主要会计数据、财务指标发生变动的情况、原因 持股5%以上 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥38,661,101.09, representing a 34.85% increase compared to ¥28,670,179.99 in the same period last year[4]. - The net profit attributable to shareholders was -¥5,301,909.06, a decrease of 215.97% from ¥4,571,726.52 in the previous year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥7,393,596.85, down 320.24% from ¥3,357,116.13 year-on-year[4]. - Net profit for Q1 2025 was a loss of ¥6,121,932.54, compared to a profit of ¥3,276,392.33 in Q1 2024[20]. - The total comprehensive income for the period was -6,121,932.54 RMB, compared to 3,276,392.33 RMB in the previous period, marking a decline of approximately 287%[21]. Cash Flow - The cash flow from operating activities was -¥5,629,481.95, a decline of 123.86% compared to ¥23,596,244.96 in the same period last year[5]. - In Q1 2025, the company's operating cash flow was -5,629,481.95 RMB, a significant decrease from 23,596,244.96 RMB in Q1 2024, indicating a decline of approximately 124% year-over-year[23]. - Total cash inflow from operating activities in Q1 2025 was 37,817,602.02 RMB, down 40.5% from 63,642,173.32 RMB in Q1 2024[24]. - Cash and cash equivalents at the end of Q1 2025 were 176,081,617.44 RMB, down from 238,364,031.05 RMB at the end of Q1 2024, representing a decrease of approximately 26%[25]. - The company incurred cash outflows from investing activities of 45,505,702.46 RMB in Q1 2025, compared to 82,333,578.89 RMB in Q1 2024, reflecting a reduction of about 44.8%[25]. - Cash inflow from financing activities was 4,696,865.58 RMB in Q1 2025, contrasting with an outflow of -11,212,636.27 RMB in Q1 2024, indicating a turnaround in financing cash flow[25]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,795,748,384.28, a decrease of 1.44% from ¥1,822,019,588.53 at the end of the previous year[5]. - Total liabilities decreased to ¥151,110,382.89 from ¥171,259,654.60 year-over-year[17]. - The company's equity attributable to shareholders decreased slightly to ¥1,602,701,069.83 from ¥1,608,002,978.89 year-over-year[18]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 5,382[9]. - The total number of shares held by the top 10 shareholders includes 4,610,000 shares by Ningbo Tongtai Xin Venture Capital Partnership and 2,460,000 shares by Ningbo Tongyuan Youbo Venture Capital Partnership[10]. - The top shareholder, Hai Luo Chuang Tou Holdings (Zhuhai) Co., Ltd., holds 426,602 shares, with no shares held in ordinary securities accounts[11]. Regulatory and Compliance - The company received an administrative regulatory measure decision from the China Securities Regulatory Commission on January 17, 2025, which is being addressed with corrective measures[12]. - The company held a board meeting on April 25, 2025, to review and approve corrections related to prior accounting errors and periodic report adjustments[14]. - The company is focused on compliance and has implemented specific rectification measures in response to regulatory feedback[13]. Research and Development - Research and development expenses totaled ¥5,122,522.39, accounting for 13.25% of operating revenue, down from 20.48% in the previous year[5]. - Research and development expenses for Q1 2025 were ¥5,122,522.39, a decrease from ¥5,872,639.91 in Q1 2024[19]. Inventory and Receivables - The company experienced an increase in inventory unit costs and recognized inventory impairment provisions, impacting net profit negatively[8]. - The company attributed the decline in net profit to increased depreciation costs and a decrease in cash collection from major clients[8]. - Accounts receivable increased to ¥167,516,216.89 from ¥165,084,679.92, reflecting a slight growth of about 1.5%[15]. - The company’s other receivables amounted to ¥2,837,160.81, showing a slight increase from ¥2,562,833.11[15]. - The company’s prepayments rose significantly to ¥4,690,813.10 from ¥2,819,681.48, marking an increase of approximately 66%[15]. Future Outlook - The company plans to focus on market expansion and new product development in the upcoming quarters[19]. - The company's financial report for the first quarter of 2025 is unaudited, indicating a need for further review before finalization[15].

关于 2025 年第一季度计提资产减值准备的公告 证券代码：688053 证券简称：思科瑞 公告编号：2025-023 成都思科瑞微电子股份有限公司 为真实反映公司的财务状况、资产价值及经营情况，根据《企业会计准则》以 及公司会计政策、会计估计的相关规定，本着谨慎性原则，公司对合并报表范围内 截至2025年3月31日的存货进行了减值测试。经测试，2025年第一季度计提资产减值 损失469.21万元，其中存货跌价损失469.21万元。 三、本次计提减值准备对公司的影响 一、2025 年一季度计提资产减值准备情况 根据《企业会计准则》和相关会计政策的相关规定，结合公司的实际情况，为 了真实、准确地反映公司 2025 年第一季度的财务状况和经营成果，基于谨慎性原 则，公司拟对截至 2025年3月31 日合并报表范围内可能发生信用及资产减值损失的 有关资产计提资产减值准备。 2025年第一季度，公司计提资产减值损失和信用减值损失共计896.28万元，具 体如下： 二、 计提减值准备事项的具体说明 （一）信用减值损失 为真实反映公司的财务状况、资产价值及经营情况，根据《企业会计准则》以 及公司会计政策、会计估计的相关规 ...

本次公司不分配不转赠。 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 一、主要会计数据和财务指标 | 名称 | 持有数量(万股) | 占总股本 | 增减情况 | | --- | --- | --- | --- | | | | 比例(%) | (万股) | | 宁波通泰信创业投资合伙企业(有限合伙) | 461.00 | 10.65 | -41.00 | | 宁波通元优博创业投资合伙企业(有限合伙) | 246.00 | 5.68 | 不变 | | 混沌天成期货股份有限公司 | 135.05 | 3.12 | 不变 | | 何红梅 | 119.00 | 2.75 | 不变 | | 苏刚 | 92.01 | 2.13 | 12.01 | | 宁波松瓴创业投资合伙企业(有限合伙) | 60.00 | 1.39 | 不变 | | 胡丽君 | 50.48 | 1.17 | 新进 | | 海螺创投控股(珠海)有限公司 | 42.66 | 0.99 | -27.03 | | 程聪 | 36.98 | 0.85 | 新进 | | 四川发展证券投资基金管理有限公司-四川资本市场纾困发展 证券投资基金合 ...

思科瑞公告，2025年第一季度营收为3866.11万元，同比增长34.85%；净亏损530.19万元，去年同期净 利润457.17万元。 ...

Financial Performance - The net profit attributable to ordinary shareholders for 2023 is RMB 43,097,713.78, with a distributable profit of RMB 106,778,476.52 as of December 31, 2023[7]. - The proposed cash dividend is RMB 3.10 per 10 shares, totaling RMB 30,711,800.13, which represents 71.26% of the net profit attributable to shareholders[8]. - The company's revenue for 2023 was CNY 200,838,880.34, a decrease of 13.75% compared to the previous year[26]. - Net profit attributable to shareholders for 2023 was CNY 47,840,488.21, down 47.68% from the previous year[26]. - Adjusted net profit for 2023 was CNY 42,481,749.53, reflecting a decline of 47.78% year-over-year[26]. - The net profit attributable to shareholders decreased by 47.69%, primarily due to a decline in operating revenue compared to the same period last year, alongside increased costs from expanded testing capabilities[32]. - The gross margin decreased from 67.85% in 2022 to 53.97% in 2023, indicating a significant decline in profitability[107]. - The operating costs increased by 23.46% year-on-year, amounting to CNY 92.44 million[119]. - The company reported a significant increase in net cash flow from operating activities, up 143.65% to CNY 69.83 million[119]. - The company's cash and cash equivalents rose by 84.04% to CNY 308.30 million, reflecting improved liquidity[149]. Audit and Compliance - The company has received a standard unqualified audit report from Zhonghui Certified Public Accountants[6]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[10]. - The company has not disclosed any special arrangements for corporate governance[9]. - The company has established a robust internal control system to enhance governance and ensure compliance with relevant laws and regulations[175]. - The board of directors consists of 7 members, including 3 independent directors, ensuring compliance with legal requirements[176]. Research and Development - Research and development expenses accounted for 11.10% of operating revenue, up from 9.16% in the previous year[30]. - R&D investment in 2023 was 22.30 million yuan, an increase of 4.53% year-on-year, resulting in the acquisition of 14 invention patents and 30 software copyrights[43]. - The total R&D investment for the year reached ¥22,296,614.18, representing a 4.53% increase from the previous year, with R&D expenses accounting for 11.10% of total revenue[91]. - The company has developed over 36,000 testing software programs, a 28.5% increase year-on-year, and over 23,000 testing adapters, a 25.1% increase year-on-year[99]. - The company has established a comprehensive R&D system focused on reliability testing technologies and processes, continuously improving its service capabilities[66]. Market and Industry Position - The detection service industry in China has over 54,000 institutions, generating a service output value exceeding 400 billion yuan, indicating significant market potential[74]. - The military electronic component reliability testing market is expected to grow in correlation with China's increasing military expenditure, which rose from 33.2% in 2010 to 40.00% in 2019[162]. - The company is positioned in a recovery cycle similar to the global detection industry in 2010, suggesting potential for performance improvement and value reassessment in 2023[77]. - The company has established reliability testing service bases in Chengdu, Wuxi, and Xi'an, strategically located in key military equipment production areas[78]. - The company benefits from a favorable market environment as the regulatory framework for the detection industry becomes more open and market-oriented, providing growth opportunities[81]. Operational Challenges - The company faced a decline in detection order volume due to delays in military orders, impacting overall operational performance[102]. - The company is experiencing a low capacity utilization rate due to a downturn in the military industry, which may continue to affect its financial performance[106]. - The company’s reliance on military electronic component reliability testing exposes it to risks from potential quality accidents that could damage its reputation[105]. - The company must continuously invest in technology development to keep pace with rapid advancements in electronic components, or risk falling behind in the market[104]. - The company faces challenges such as a rapid increase in the variety of electronic components and a shortage of high-end professional talent in the reliability testing industry[83]. Corporate Governance - The company has not reported any changes in the implementation of differential voting rights during the reporting period[186]. - The company has not established a red-chip structure for corporate governance[187]. - The total remuneration for the chairman is reported at 600,000 yuan for the year[188]. - The company has seen a stable leadership structure with independent directors serving terms until 2026, ensuring continuity in governance[191]. - The company has strengthened investor relations management through various communication channels, ensuring timely and accurate information disclosure[180]. Future Plans and Strategies - The company aims to establish a first-class reliability service platform and expand its operations in Chengdu, Wuxi, Xi'an, and Hainan, focusing on environmental testing and electromagnetic compatibility projects[166]. - The company plans to accelerate the construction of reliability testing centers in key regions, enhancing its production capacity and competitive strength in the market[167]. - The company will leverage advanced technology to develop an integrated reliability testing center in Wenchang, aiming for high efficiency and low-cost solutions for aerospace products[167]. - The company plans to expand its testing and experimental service capabilities by establishing multiple new testing bases and laboratories, particularly in the southwest, northwest, and eastern regions of China[170]. - Over the next three years, the company will deepen organizational structure reforms to enhance management efficiency and strengthen the construction of functional departments[171].